GRANULES INDIA LIMITED
Regd Office : 2nd Floor, 3rd Block, My Home Hub
Madhapur, Hyderabad 500 081
UNAUDITED FINANCIAL RESULTS 
FOR THE QUARTER  ENDED 31st MARCH, 2008
Rs. Lakhs
S No Particulars Quarter ended             31st March   2008 Quarter ended             31st March 2007 9 Months    ended             31st March 2008 9 Months     ended             31st March 2007       Audited previous accounting year ended 30th June 2007 
1 Gross sales      5,221.77       4,757.15      16,058.98     14,870.07              19,519.33
  Less : Excise Duty & Sales tax        275.05          214.31          815.03          767.41                   949.23
2 Net sales/ Income from operations      4,946.72       4,542.84      15,243.95     14,102.66              18,570.10
3 Other Income          22.69            60.92            72.06          130.28                   246.31
4 Total expenditure          
  a) (Increase)/decrease in stock in trade       (472.35)            30.50         (592.31)         (489.38)                     13.23
  b) Material consumption      3,336.79       2,577.59       9,403.65       8,664.36              10,720.73
  c) Manufacturing expenses        436.42          409.51       1,304.00       1,178.87                1,588.94
  d) Employee cost        330.35          283.81       1,055.66          878.45                1,200.97
  e) Other expenditure        483.36          435.60       1,669.70       1,460.70                1,923.29
5 EBIDTA (2-4)        832.16          805.83       2,403.25       2,409.66                3,122.94
6 Interest and finance charges        300.32          303.27          860.98          930.10                1,202.85
7 Depreciation        249.56          197.08          717.59          613.99                   817.73
8 Profit before taxation         304.97          366.40          896.74          995.85                1,348.67
9 Current tax expense           29.54            11.51            87.69           24.17                     43.93
10 Deferred tax expense          70.70            68.20          168.45          172.71                   283.65
11 Fringe Benefit  Tax             3.04             2.13              8.44             6.19                      9.11
12 Net Profit        201.69          284.56          632.16          792.78                1,011.98
13 Paid up share capital      2,005.72       1,257.46       2,005.72       1,257.46                2,002.36
   (face value of Rs. 10/- each)          
14 Reserves excluding Revaluation reserve                       15,262.42
15 Basic Earnings per share (Rs.)*            1.01             2.26              3.15             6.30                      7.63
16 Diluted Earnings per share (Rs.)*            0.93             1.86              2.92             5.17                      6.81
17 No. of equity shares  20,057,154    12,574,609    20,057,154   12,574,609             20,023,634
18 Aggregate of Public Share holding:          
   - Number of shares  13,547,423     7,221,758    13,547,423     7,221,758             13,670,603
   - Percentage of share holding 67.54% 57.43% 67.54% 57.43% 68.27%
* Not Annualised for quarter ending
NOTES :
1) The above  results were reviewed by the Audit Committee and approved by the  Board at its meeting held  on 30th April,
     2008 and were subjected to limited review by Statutory Auditors.
2) The company has not received any complaints from investors during the quarter 1st January '08 to 31st March'08
    and no complaints were pending from previous quarter.
3) The company operates only in the segment of Pharmaceuticals.
4) Diluted EPS includes 16,00,000 share warrants which are yet to be converted.
5) Figures are regrouped wherever necessary.
for and on behalf of the Board
Place  : Hyderabad         Dr.C.Nageswara Rao
Date   :  30.04.2008                 Chairman